|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/34 | |
| C12N 5/077 | |||
| A61P 25/00 |
| (11) | Number of the document | 2680864 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12711003.9 |
| Date of filing the European patent application | 2012-03-01 | |
| (97) | Date of publication of the European application | 2014-01-08 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2012/050976 |
| Date | 2012-03-01 |
| (87) | Number | WO 2012/117373 |
| Date | 2012-09-07 |
| (30) | Number | Date | Country code |
| 201161448712 P | 2011-03-03 | US |
| (72) |
OFFEN, Daniel, IL
DADON-NACHUM, Michal, IL
BEN-ZUR, Tali, IL
MELAMED, Eldad, IL
YAFFE, David, IL
|
| (73) |
Ramot at Tel-Aviv University Ltd.,
P.O. Box 39296, 61392 Tel Aviv,
IL
Yeda Research and Development Co. Ltd., At the Weizmann Institute of Science P.O. Box 95, 76100 Rehovot, IL |
| (54) | GENETICALLY MODIFIED MUSCLE CELLS WHICH EXPRESS NEUROTROPHIC FACTORS |
| GENETICALLY MODIFIED MUSCLE CELLS WHICH EXPRESS NEUROTROPHIC FACTORS |